CIS Insulin Market By Product Type (Long Acting, Premixed, Short Acting, Rapid Acting & Intermediate Acting), Source (Human Recombinant & Analogs) and Application (Type I Diabetes, Type II Diabetes & Other Diabetes) - Global Industry Analysis And Forecast To 2025

Published On : August 2018 Pages : 180 Category: Pharmaceuticals Report Code : HC081233

Industry Outlook

Insulin is hormone created by pancreases that makes body to extract sugar (glucose) from carbohydrates for using & storing it for future use. Insulin tackles blood sugar level problems like hypoglycemia (low sugar) & hyperglycemia (high sugar). Sugar is needed by cells for energy, but the sugar cannot directly be used by cells. Insulin comes in role at this stage by opening up the cells to make the sugar enter them for providing energy. Insulin also helps in storing the sugar and using it when needed (like in case of decreased sugar levels or when body needs extra sugar). If the production of Insulin decreases in the body it causes hyperglycemia. Therefore, the CIS Insulin Market is anticipated to expand and has tremendous scope during the forecast period. The global CIS Insulin Market anticipated to flourish in the future by growing at a significantly higher CAGR.

Market Segmentation

The global CIS Insulin Market is based on segment, by Product Type the market is segmented into Long Acting, Premixed, Short Acting, Rapid Acting & Intermediate Acting, by Source the market is segmented into Human Recombinant & Analogs, and by Application the market is segmented into Type I Diabetes, Type II Diabetes & Other Diabetes.

  • CIS Insulin Market, By Product Type
  • Long Acting
  • Premixed
  • Short Acting
  • Rapid Acting
  • Intermediate Acting
  • CIS Insulin Market, By Source
  • Human Recombinant
  • Analogs
  • CIS Insulin Market, By Application
  • Type I Diabetes
  • Type II Diabetes
  • Other Diabetes

Regional Insights

On a global front, the CIS Insulin Market covers North America (United States, Canada and Mexico), Europe (Germany, UK, France, Russia, Italy, Rest of Europe), Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific), South America (Brazil, Argentina, Columbia, Rest of South America) and Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA). North American region is leading the global CIS Insulin Market pursued by European & Asia Pacific region.

CIS Insulin Market, By Region

    • North America
  • U.S.
  • Canada
  • Mexico
    • Europe
  • Germany
  • UK
  • France
  • Russia
  • Italy
  • Rest of Europe
    • Asia-Pacific
  • China
  • Japan
  • South Korea
  • India
  • Southeast Asia
  • Rest of Asia-Pacific
    • South America
  • Brazil
  • Argentina
  • Columbia
  • Rest of South America
    • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Egypt
  • Nigeria
  • South Africa
  • Rest of MEA

Competitive Analysis

The leading players in the market are Biocon, Merck & Co. Inc., Sanofi Aventis, Eli Lilly and Company, Boehringer Ingelheim, Oramed Pharmaceuticals, Nanjing Xinbai Pharmaceutical Co. Ltd., Novo Nordisk and Takeda Pharmaceuticals. The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and market share of the overall industry.

  • Biocon
  • Merck & Co. Inc.
  • Sanofi Aventis
  • Eli Lilly and Company
  • Boehringer Ingelheim
  • Oramed Pharmaceuticals
  • Nanjing Xinbai Pharmaceutical Co. Ltd.
  • Novo Nordisk
  • Takeda Pharmaceuticals

Some of the key questions answered by the report are:          

  • What was the market size in 2014 and forecast from 2015 to 2025?
  • What will be the industry market growth from 2015 to 2025?
  • What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
  • What are the major segments leading the market growth and why?
  • Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?

Market Classification

o   CIS Insulin Market, By Product Type, Estimates and Forecast, 2014-2025 ($Million)

o   Long Acting

o   Premixed

o   Short Acting

o   Rapid Acting

o   Intermediate Acting

o   CIS Insulin Market, By Source, Estimates and Forecast, 2014-2025 ($Million)

o   Human Recombinant

o   Analogs

o   CIS Insulin Market, By Application, Estimates and Forecast, 2014-2025 ($Million)

o   Type I Diabetes

o   Type II Diabetes

o   Other Diabetes

CIS Insulin Market, By Region, Estimates and Forecast, 2014-2025 ($Million)

o   North America

§  North America CIS Insulin Market, By Country

o   U.S. CIS Insulin Market

o   Canada CIS Insulin Market

o   Mexico CIS Insulin Market

o   Europe

§  Europe CIS Insulin Market, By Country

o   Germany CIS Insulin Market

o   UK CIS Insulin Market

o   France CIS Insulin Market

o   Russia CIS Insulin Market

o   Italy CIS Insulin Market

o   Rest of Europe CIS Insulin Market

o   Asia-Pacific

§  Asia-Pacific CIS Insulin Market, By Country

o   China CIS Insulin Market

o   Japan CIS Insulin Market

o   South Korea  CIS Insulin Market

o   India CIS Insulin Market

o   Southeast Asia CIS Insulin Market

o   Rest of Asia-Pacific CIS Insulin Market

o   South America

§  South America CIS Insulin Market, By Country

o   Brazil CIS Insulin Market

o   Argentina CIS Insulin Market

o   Columbia CIS Insulin Market

o   Rest of South America CIS Insulin Market

o   Middle East and Africa

§  Middle East and Africa CIS Insulin Market, By Country

o   Saudi Arabia CIS Insulin Market

o   UAE CIS Insulin Market

o   Egypt CIS Insulin Market

o   Nigeria CIS Insulin Market

o   South Africa CIS Insulin Market

o   Rest of MEA CIS Insulin Market

Table of Contents

1.       Introduction

1.1.     Report Description

2.       Executive Summary

2.1.     Key Highlights

3.       Market Overview

3.1.     Introduction

3.1.1.  Market Definition

3.1.2.  Market Segmentation

3.2.     Market Dynamics

3.2.1.  Drivers

3.2.2.  Restraints

3.2.3.  Opportunities

3.3.     SWOT Analysis

4.       Market Analysis by Regions

4.1.     North America (United States, Canada and Mexico)

4.1.1.  United States Market Status and Outlook (2014-2025)

4.1.2.  Canada Market Status and Outlook (2014-2025)

4.1.3.  Mexico Market Status and Outlook (2014-2025)

4.2.     Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

4.2.1.  Germany Market Status and Outlook (2014-2025)

4.2.2.  France Market Status and Outlook (2014-2025)

4.2.3.  UK Market Status and Outlook (2014-2025)

4.2.4.  Russia Market Status and Outlook (2014-2025)

4.2.5.  Italy Market Status and Outlook (2014-2025)

4.2.6.  Rest of Europe Market Status and Outlook (2014-2025)

4.3.     Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)

4.3.1.  China Market Status and Outlook (2014-2025)

4.3.2.  Japan Market Status and Outlook (2014-2025)

4.3.3.  Korea Market Status and Outlook (2014-2025)

4.3.4.  India Market Status and Outlook (2014-2025)

4.3.5.  Southeast Asia Market Status and Outlook (2014-2025)

4.3.6.  Rest of Asia-Pacific Market Status and Outlook (2014-2025)

4.4.     South America (Brazil, Argentina, Columbia and Rest of South America)

4.4.1.  Brazil Market Status and Outlook (2014-2025)

4.4.2.  Argentina Market Status and Outlook (2014-2025)

4.4.3.  Columbia Market Status and Outlook (2014-2025)

4.4.4.  Rest of South America Market Status and Outlook (2014-2025)

4.5.     Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)

4.5.1.  Saudi Arabia Market Status and Outlook (2014-2025)

4.5.2.  United Arab Emirates Market Status and Outlook (2014-2025)

4.5.3.  Egypt Market Status and Outlook (2014-2025)

4.5.4.  Nigeria Market Status and Outlook (2014-2025)

4.5.5.  South Africa Market Status and Outlook (2014-2025)

4.5.6.  Turkey Market Status and Outlook (2014-2025)

4.5.7.  Rest of Middle East and Africa Market Status and Outlook (2014-2025)

5.       CIS Insulin  Market, By Product Type

5.1.     Introduction

5.2.     Global CIS Insulin  Revenue and Market Share by Product Type (2014-2018)

5.2.1.  Global CIS Insulin  Revenue and Revenue Share by Product Type (2014-2018)

5.3.     Long Acting

5.3.1.  Global Long Acting  Revenue and Growth Rate (2014-2018)

5.4.     Premixed

5.4.1.  Global Premixed Revenue and Growth Rate (2014-2018)

5.5.     Short Acting

5.5.1.  Global Short Acting  Revenue and Growth Rate (2014-2018)

5.6.     Rapid Acting

5.6.1.  Global Rapid Acting Revenue and Growth Rate (2014-2018)

5.7.     Intermediate Acting

5.7.1.  Global Intermediate Acting  Revenue and Growth Rate (2014-2018)

6.       CIS Insulin  Market, By Source

6.1.     Introduction

6.2.     Global CIS Insulin  Revenue and Market Share by Source (2014-2018)

6.2.1.  Global CIS Insulin  Revenue and Revenue Share by Source (2014-2018)

6.3.     Human Recombinant

6.3.1.  Global Human Recombinant  Revenue and Growth Rate (2014-2018)

6.4.     Analogs

6.4.1.  Global Analogs  Revenue and Growth Rate (2014-2018)

7.       CIS Insulin  Market, By Application

7.1.     Introduction

7.2.     Global CIS Insulin  Revenue and Market Share by Application (2014-2018)

7.2.1.  Global CIS Insulin  Revenue and Revenue Share by Application (2014-2018)

7.3.     Type I Diabetes

7.3.1.  Global Type I Diabetes Revenue and Growth Rate (2014-2018)

7.4.     Type II Diabetes

7.4.1.  Global Type II Diabetes Revenue and Growth Rate (2014-2018)

7.5.     Other Diabetes

7.5.1.  Global Other Diabetes Revenue and Growth Rate (2014-2018)

8.       CIS Insulin  Market, By Region

8.1.     Introduction

8.2.     Global CIS Insulin  Revenue and Market Share by Regions

8.2.1.  Global CIS Insulin  Revenue by Regions (2014-2018)

8.3.     North America CIS Insulin  by Countries

8.3.1.  North America CIS Insulin  Revenue and Growth Rate (2014-2018)

8.3.2.  North America CIS Insulin  Revenue (Million USD) by Countries (2014-2018)

8.3.3.  United States

8.3.3.1.  United States CIS Insulin  Revenue (Millions USD) and Growth Rate (2014-2018)

8.3.4.  Canada

8.3.4.1.  Canada CIS Insulin  Revenue (Millions USD) and Growth Rate (2014-2018)

8.3.5.  Mexico

8.3.5.1.  Mexico CIS Insulin  Revenue (Millions USD) and Growth Rate (2014-2018)

8.4.     Europe CIS Insulin  by Countries

8.4.1.  Europe CIS Insulin  Revenue and Growth Rate (2014-2018)

8.4.2.  Europe CIS Insulin  Revenue (Million USD) by Countries (2014-2018)

8.4.3.  Germany

8.4.3.1.  Germany CIS Insulin  Revenue (Millions USD) and Growth Rate (2014-2018)

8.4.4.  France

8.4.4.1.  France CIS Insulin  Revenue (Millions USD) and Growth Rate (2014-2018)

8.4.5.  UK

8.4.5.1.  UK CIS Insulin  Revenue (Millions USD) and Growth Rate (2014-2018)

8.4.6.  Russia

8.4.6.1.  Russia CIS Insulin  Revenue (Millions USD) and Growth Rate (2014-2018)

8.4.7.  Italy

8.4.7.1.  Italy CIS Insulin  Revenue (Millions USD) and Growth Rate (2014-2018)

8.4.8.  Rest of Europe

8.4.8.1.  Rest of Europe CIS Insulin  Revenue (Millions USD) and Growth Rate (2014-2018)

8.5.     Asia-Pacific CIS Insulin  by Countries

8.5.1.  Asia-Pacific CIS Insulin  Revenue and Growth Rate (2014-2018)

8.5.2.  Asia-Pacific CIS Insulin  Revenue (Million USD) by Countries (2014-2018)

8.5.3.  China

8.5.3.1.  China CIS Insulin  Revenue (Millions USD) and Growth Rate (2014-2018)

8.5.4.  Japan

8.5.4.1.  Japan CIS Insulin  Revenue (Millions USD) and Growth Rate (2014-2018)

8.5.5.  Korea

8.5.5.1.  Korea CIS Insulin  Revenue (Millions USD) and Growth Rate (2014-2018)

8.5.6.  India

8.5.6.1.  India CIS Insulin  Revenue (Millions USD) and Growth Rate (2014-2018)

8.5.7.  Southeast Asia

8.5.7.1.  Southeast Asia CIS Insulin  Revenue (Millions USD) and Growth Rate (2014-2018)

8.5.8.  Rest of Asia-Pacific

8.5.8.1.  Rest of Asia-Pacific CIS Insulin  Revenue (Millions USD) and Growth Rate (2014-2018)

8.6.     South America CIS Insulin  by Countries

8.6.1.  South America CIS Insulin  Revenue and Growth Rate (2014-2018)

8.6.2.  South America CIS Insulin  Revenue (Million USD) by Countries (2014-2018)

8.6.3.  Brazil

8.6.3.1.  Brazil CIS Insulin  Revenue (Millions USD) and Growth Rate (2014-2018)

8.6.4.  Argentina

8.6.4.1.  Argentina CIS Insulin  Revenue (Millions USD) and Growth Rate (2014-2018)

8.6.5.  Columbia

8.6.5.1.  Columbia CIS Insulin  Revenue (Millions USD) and Growth Rate (2014-2018)

8.6.6.  Rest of South America

8.6.6.1.  Rest of South America CIS Insulin  Revenue (Millions USD) and Growth Rate (2014-2018)

8.7.     Middle East and Africa CIS Insulin  by Countries

8.7.1.  Middle East and Africa CIS Insulin  Revenue and Growth Rate (2014-2018)

8.7.2.  Middle East and Africa CIS Insulin  Revenue (Million USD) by Countries (2014-2018)

8.7.3.  Saudi Arabia

8.7.3.1.  Saudi Arabia CIS Insulin  Revenue (Millions USD) and Growth Rate (2014-2018)

8.7.4.  United Arab Emirates

8.7.4.1.  United Arab Emirates CIS Insulin  Revenue (Millions USD) and Growth Rate (2014-2018)

8.7.5.  Egypt

8.7.5.1.  Egypt CIS Insulin  Revenue (Millions USD) and Growth Rate (2014-2018)

8.7.6.  Nigeria

8.7.6.1.  Nigeria CIS Insulin  Revenue (Millions USD) and Growth Rate (2014-2018)

8.7.7.  South Africa

8.7.7.1.  South Africa CIS Insulin  Revenue (Millions USD) and Growth Rate (2014-2018)

8.7.8.  Turkey

8.7.8.1.  Turkey CIS Insulin  Revenue (Millions USD) and Growth Rate (2014-2018)

8.7.9.  Rest of Middle East and Africa

8.7.9.1.  Rest of Middle East and Africa CIS Insulin  Revenue (Millions USD) and Growth Rate (2014-2018)

9.       Company Profiles

9.1.     Biocon

9.1.1.  Business Overview

9.1.2.   Service Portfolio

9.1.3.  Strategic Developments

9.1.4.   Revenue and Market Share

9.2.     Merck & Co. Inc.

9.2.1.  Business Overview

9.2.2.   Service Portfolio

9.2.3.  Strategic Developments

9.2.4.   Revenue and Market Share

9.3.     Sanofi Aventis

9.3.1.  Business Overview

9.3.2.   Service Portfolio

9.3.3.  Strategic Developments

9.3.4.   Revenue and Market Share

9.4.     Eli Lilly and Company

9.4.1.  Business Overview

9.4.2.   Service Portfolio

9.4.3.  Strategic Developments

9.4.4.   Revenue and Market Share

9.5.     Boehringer Ingelheim

9.5.1.  Business Overview

9.5.2.   Service Portfolio

9.5.3.  Strategic Developments

9.5.4.   Revenue and Market Share

9.6.     Oramed Pharmaceuticals

9.6.1.  Business Overview

9.6.2.   Service Portfolio

9.6.3.  Strategic Developments

9.6.4.   Revenue and Market Share

9.7.     Nanjing Xinbai Pharmaceutical Co. Ltd.

9.7.1.  Business Overview

9.7.2.   Service Portfolio

9.7.3.  Strategic Developments

9.7.4.   Revenue and Market Share

9.8.     Novo Nordisk

9.8.1.  Business Overview

9.8.2.   Service Portfolio

9.8.3.  Strategic Developments

9.8.4.   Revenue and Market Share

9.9.     Takeda Pharmaceuticals

9.9.1.  Business Overview

9.9.2.   Service Portfolio

9.9.3.  Strategic Developments

9.9.4.   Revenue and Market Share

10.    Global CIS Insulin  Market Competition, by Manufacturer

10.1. Global CIS Insulin  Revenue and Market Share by Manufacturer (2016-2017)

10.2. Global CIS Insulin  Price By Region (2016-2017)

10.3. Top 5 CIS Insulin  Manufacturer Market Share

10.4. Market Competition Trend

11.    CIS Insulin  Market Forecast (2018-2025)

11.1. Global CIS Insulin  Revenue (Millions USD) and Growth Rate (2018-2025)

11.2. CIS Insulin  Market Forecast by Regions (2018-2025)

11.2.1.      North America CIS Insulin  Market Forecast (2018-2025)

11.2.1.1. United States CIS Insulin  Market Forecast (2018-2025)

11.2.1.2. Canada CIS Insulin  Market Forecast (2018-2025)

11.2.1.3. Mexico CIS Insulin  Market Forecast (2018-2025)

11.2.2.      Europe CIS Insulin  Market Forecast (2018-2025)

11.2.2.1. Germany CIS Insulin  Market Forecast (2018-2025)

11.2.2.2. France CIS Insulin  Market Forecast (2018-2025)

11.2.2.3. UK CIS Insulin  Market Forecast (2018-2025)

11.2.2.4. Russia CIS Insulin  Market Forecast (2018-2025)

11.2.2.5. Italy CIS Insulin  Market Forecast (2018-2025)

11.2.2.6. Rest of Europe CIS Insulin  Market Forecast (2018-2025)

11.2.3.      Asia-Pacific CIS Insulin  Market Forecast (2018-2025)

11.2.3.1. China CIS Insulin  Market Forecast (2018-2025)

11.2.3.2. Japan CIS Insulin  Market Forecast (2018-2025)

11.2.3.3. Korea CIS Insulin  Market Forecast (2018-2025)

11.2.3.4. India CIS Insulin  Market Forecast (2018-2025)

11.2.3.5. Southeast Asia CIS Insulin  Market Forecast (2018-2025)

11.2.3.6. Rest of Asia-Pacific CIS Insulin  Market Forecast (2018-2025)

11.2.4.      South America CIS Insulin  Market Forecast (2018-2025)

11.2.4.1. Brazil CIS Insulin  Market Forecast (2018-2025)

11.2.4.2. Argentina CIS Insulin  Market Forecast (2018-2025)

11.2.4.3. Columbia CIS Insulin  Market Forecast (2018-2025)

11.2.4.4. Rest of South America CIS Insulin  Market Forecast (2018-2025)

11.2.5.      Middle East and Africa CIS Insulin  Market Forecast (2018-2025)

11.2.5.1. Saudi Arabia CIS Insulin  Market Forecast (2018-2025)

11.2.5.2. United Arab Emirates CIS Insulin  Market Forecast (2018-2025)

11.2.5.3. Egypt CIS Insulin  Market Forecast (2018-2025)

11.2.5.4. Nigeria CIS Insulin  Market Forecast (2018-2025)

11.2.5.5. South Africa CIS Insulin  Market Forecast (2018-2025)

11.2.5.6. Turkey CIS Insulin  Market Forecast (2018-2025)

11.2.5.7. Rest of Middle East and Africa CIS Insulin  Market Forecast (2018-2025)

11.3. CIS Insulin  Market Forecast by Product Type (2018-2025)

11.3.1.      CIS Insulin  Forecast by Product Type (2018-2025)

11.3.2.      CIS Insulin  Market Share Forecast by Product Type (2018-2025)

11.4. CIS Insulin  Market Forecast by Source (2018-2025)

11.4.1.      CIS Insulin  Forecast by Source (2018-2025)

11.4.2.      CIS Insulin  Market Share Forecast by Source (2018-2025)

11.5. CIS Insulin  Market Forecast by Application (2018-2025)

11.5.1.      CIS Insulin  Forecast by Application (2018-2025)

11.5.2.      CIS Insulin  Market Share Forecast by Application (2018-2025)


List of Tables

12. List of Tables and Figures
Figure United States CIS Insulin Revenue (Million USD) and Growth Rate (2014-2025)
Figure Canada CIS Insulin Revenue (Million USD) and Growth Rate (2014-2025)
Figure Mexico CIS Insulin Revenue (Million USD) and Growth Rate (2014-2025)
Figure Germany CIS Insulin Revenue (Million USD) and Growth Rate (2014-2025)
Figure France CIS Insulin Revenue (Million USD) and Growth Rate (2014-2025)
Figure UK CIS Insulin Revenue (Million USD) and Growth Rate (2014-2025)
Figure Russia CIS Insulin Revenue (Million USD) and Growth Rate (2014-2025)
Figure Italy CIS Insulin Revenue (Million USD) and Growth Rate (2014-2025)
Figure Rest of Europe CIS Insulin Revenue (Million USD) and Growth Rate (2014-2025)
Figure China CIS Insulin Revenue (Million USD) and Growth Rate (2014-2025)
Figure Japan CIS Insulin Revenue (Million USD) and Growth Rate (2014-2025)
Figure Korea CIS Insulin Revenue (Million USD) and Growth Rate (2014-2025)
Figure India CIS Insulin Revenue (Million USD) and Growth Rate (2014-2025)
Figure Southeast Asia CIS Insulin Revenue (Million USD) and Growth Rate (2014-2025)
Figure Rest of Asia-Pacific CIS Insulin Revenue (Million USD) and Growth Rate (2014-2025)
Figure Brazil CIS Insulin Revenue (Million USD) and Growth Rate (2014-2025)
Figure Argentina CIS Insulin Revenue (Million USD) and Growth Rate (2014-2025)
Figure Columbia CIS Insulin Revenue (Million USD) and Growth Rate (2014-2025)
Figure Rest of South America CIS Insulin Revenue (Million USD) and Growth Rate (2014-2025)
Figure Saudi Arabia CIS Insulin Revenue (Million USD) and Growth Rate (2014-2025)
Figure United Arab Emirates CIS Insulin Revenue (Million USD) and Growth Rate (2014-2025)
Figure Egypt CIS Insulin Revenue (Million USD) and Growth Rate (2014-2025)
Figure Nigeria CIS Insulin Revenue (Million USD) and Growth Rate (2014-2025)
Figure South Africa CIS Insulin Revenue (Million USD) and Growth Rate (2014-2025)
Figure Turkey CIS Insulin Revenue (Million USD) and Growth Rate (2014-2025)
Figure Rest of Middle East and Africa CIS Insulin Revenue (Million USD) and Growth Rate (2014-2025)
Table Global CIS Insulin Revenue and Revenue Share by Product Type (2014-2018)
Figure Global Long Acting Revenue and Growth Rate (2014-2018)
Figure Global Premixed Revenue and Growth Rate (2014-2018)
Figure Global Short Acting Revenue and Growth Rate (2014-2018)
Figure Global Rapid Acting Revenue and Growth Rate (2014-2018)
Figure Global Intermediate Acting Revenue and Growth Rate (2014-2018)
Table Global CIS Insulin Revenue and Revenue Share by Source (2014-2018)
Figure Global Human Recombinant Revenue and Growth Rate (2014-2018)
Figure Global Analogs Revenue and Growth Rate (2014-2018)
Table Global CIS Insulin Revenue and Revenue Share by Application (2014-2018)
Figure Global Type I Diabetes Revenue and Growth Rate (2014-2018)
Figure Global Type II Diabetes Revenue and Growth Rate (2014-2018)
Figure Global Other Diabetes Revenue and Growth Rate (2014-2018)
Table Global CIS Insulin Revenue by Regions (2014-2018)
Figure North America CIS Insulin Growth Rate (2014-2018)
Figure North America CIS Insulin Revenue and Growth Rate (2014-2018)
Figure North America CIS Insulin by Countries (2014-2018)
Figure North America CIS Insulin Revenue (Million USD) by Countries (2014-2018)
Figure United States CIS Insulin Growth Rate (2014-2018)
Figure United States CIS Insulin Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Canada CIS Insulin Growth Rate (2014-2018)
Figure Canada CIS Insulin Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Mexico CIS Insulin Growth Rate (2014-2018)
Figure Mexico CIS Insulin Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Europe CIS Insulin Growth Rate (2014-2018)
Figure Europe CIS Insulin Revenue and Growth Rate (2014-2018)
Figure Europe CIS Insulin by Countries (2014-2018)
Figure Europe CIS Insulin Revenue (Million USD) by Countries (2014-2018)
Figure Germany CIS Insulin Growth Rate (2014-2018)
Figure Germany CIS Insulin Revenue (Millions USD) and Growth Rate (2014-2018)
Figure France CIS Insulin Growth Rate (2014-2018)
Figure France CIS Insulin Revenue (Millions USD) and Growth Rate (2014-2018)
Figure UK CIS Insulin Growth Rate (2014-2018)
Figure UK CIS Insulin Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Russia CIS Insulin Growth Rate (2014-2018)
Figure Russia CIS Insulin Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Italy CIS Insulin Growth Rate (2014-2018)
Figure Italy CIS Insulin Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Rest of Europe CIS Insulin Growth Rate (2014-2018)
Figure Rest of Europe CIS Insulin Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Asia-Pacific CIS Insulin Growth Rate (2014-2018)
Figure Asia-Pacific CIS Insulin Revenue and Growth Rate (2014-2018)
Figure Asia-Pacific CIS Insulin by Countries (2014-2018)
Figure Asia-Pacific CIS Insulin Revenue (Million USD) by Countries (2014-2018)
Figure China CIS Insulin Growth Rate (2014-2018)
Figure China CIS Insulin Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Japan CIS Insulin Growth Rate (2014-2018)
Figure Japan CIS Insulin Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Korea CIS Insulin Growth Rate (2014-2018)
Figure Korea CIS Insulin Revenue (Millions USD) and Growth Rate (2014-2018)
Figure India CIS Insulin Growth Rate (2014-2018)
Figure India CIS Insulin Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Southeast Asia CIS Insulin Growth Rate (2014-2018)
Figure Southeast Asia CIS Insulin Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Rest of Asia-Pacific CIS Insulin Growth Rate (2014-2018)
Figure Rest of Asia-Pacific CIS Insulin Revenue (Millions USD) and Growth Rate (2014-2018)
Figure South America CIS Insulin Growth Rate (2014-2018)
Figure South America CIS Insulin Revenue and Growth Rate (2014-2018)
Figure South America CIS Insulin by Countries (2014-2018)
Figure South America CIS Insulin Revenue (Million USD) by Countries (2014-2018)
Figure Brazil CIS Insulin Growth Rate (2014-2018)
Figure Brazil CIS Insulin Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Argentina CIS Insulin Growth Rate (2014-2018)
Figure Argentina CIS Insulin Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Columbia CIS Insulin Growth Rate (2014-2018)
Figure Columbia CIS Insulin Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Rest of South America CIS Insulin Growth Rate (2014-2018)
Figure Rest of South America CIS Insulin Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Middle East and Africa CIS Insulin Growth Rate (2014-2018)
Figure Middle East and Africa CIS Insulin Revenue and Growth Rate (2014-2018)
Figure Middle East and Africa CIS Insulin by Countries (2014-2018)
Figure Middle East and Africa CIS Insulin Revenue (Million USD) by Countries (2014-2018)
Figure Saudi Arabia CIS Insulin Growth Rate (2014-2018)
Figure Saudi Arabia CIS Insulin Revenue (Millions USD) and Growth Rate (2014-2018)
Figure United Arab Emirates CIS Insulin Growth Rate (2014-2018)
Figure United Arab Emirates CIS Insulin Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Egypt CIS Insulin Growth Rate (2014-2018)
Figure Egypt CIS Insulin Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Nigeria CIS Insulin Growth Rate (2014-2018)
Figure Nigeria CIS Insulin Revenue (Millions USD) and Growth Rate (2014-2018)
Figure South Africa CIS Insulin Growth Rate (2014-2018)
Figure South Africa CIS Insulin Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Turkey CIS Insulin Growth Rate (2014-2018)
Figure Turkey CIS Insulin Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Rest of Middle East and Africa CIS Insulin Growth Rate (2014-2018)
Figure Rest of Middle East and Africa CIS Insulin Revenue (Millions USD) and Growth Rate (2014-2018)
Table Biocon CIS Insulin Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Merck & Co. Inc. CIS Insulin Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Sanofi Aventis CIS Insulin Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Eli Lilly and Company CIS Insulin Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Boehringer Ingelheim CIS Insulin Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Oramed Pharmaceuticals CIS Insulin Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Nanjing Xinbai Pharmaceutical Co. Ltd. CIS Insulin Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Novo Nordisk CIS Insulin Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Takeda Pharmaceuticals CIS Insulin Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global CIS Insulin Market Share by Manufacturer
Figure Global CIS Insulin Revenue and Market Share by Manufacturer
Table Global CIS Insulin Price by Region (2016-2017)
Figure Top 5 CIS Insulin Manufacturer (Revenue) Market Share
Figure Market Competition Trend
Figure Global CIS Insulin Revenue (Millions USD) and Growth Rate (2018-2025)
Table CIS Insulin Market Forecast by Regions (2018-2025)
Figure North America CIS Insulin Market Forecast (2018-2025)
Figure United States CIS Insulin Market Forecast (2018-2025)
Figure Canada CIS Insulin Market Forecast (2018-2025)
Figure Mexico CIS Insulin Market Forecast (2018-2025)
Figure Europe CIS Insulin Market Forecast (2018-2025)
Figure Germany CIS Insulin Market Forecast (2018-2025)
Figure France CIS Insulin Market Forecast (2018-2025)
Figure UK CIS Insulin Market Forecast (2018-2025)
Figure Russia CIS Insulin Market Forecast (2018-2025)
Figure Italy CIS Insulin Market Forecast (2018-2025)
Figure Rest of Europe CIS Insulin Market Forecast (2018-2025)
Figure Asia-Pacific CIS Insulin Market Forecast (2018-2025)
Figure China CIS Insulin Market Forecast (2018-2025)
Figure Japan CIS Insulin Market Forecast (2018-2025)
Figure Korea CIS Insulin Market Forecast (2018-2025)
Figure India CIS Insulin Market Forecast (2018-2025)
Figure Southeast Asia CIS Insulin Market Forecast (2018-2025)
Figure Rest of Asia-Pacific CIS Insulin Market Forecast (2018-2025)
Figure South America CIS Insulin Market Forecast (2018-2025)
Figure Brazil CIS Insulin Market Forecast (2018-2025)
Figure Argentina CIS Insulin Market Forecast (2018-2025)
Figure Columbia CIS Insulin Market Forecast (2018-2025)
Figure Rest of South America CIS Insulin Market Forecast (2018-2025)
Figure Middle East and Africa CIS Insulin Market Forecast (2018-2025)
Figure Saudi Arabia CIS Insulin Market Forecast (2018-2025)
Figure United Arab Emirates CIS Insulin Market Forecast (2018-2025)
Figure Egypt CIS Insulin Market Forecast (2018-2025)
Figure Nigeria CIS Insulin Market Forecast (2018-2025)
Figure South Africa CIS Insulin Market Forecast (2018-2025)
Figure Turkey CIS Insulin Market Forecast (2018-2025)
Figure Rest of Middle East and Africa CIS Insulin Market Forecast (2018-2025)
Figure Global CIS Insulin Forecast by Product Type (2018-2025)
Figure Global CIS Insulin Market Share Forecast by Product Type (2018-2025)
Figure Global CIS Insulin Forecast by Product Type (2018-2025)
Figure Global CIS Insulin Forecast by Source (2018-2025)
Figure Global CIS Insulin Market Share Forecast by Source (2018-2025)
Figure Global CIS Insulin Forecast by Source (2018-2025)
Figure Global CIS Insulin Forecast by Application (2018-2025)
Figure Global CIS Insulin Market Share Forecast by Application (2018-2025)
Figure Global CIS Insulin Forecast by Application (2018-2025)


Research Methodology

We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.

Data Mining

Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.

Data Collection Matrix

Data Collection Matrix

Supply Side

Demand Side

Primary Data Sources

  • Manufacturers
  • Distributors & Wholesalers
  • GPOs
  • Physicians/Specialist
  • Healthcare Providers
  • Consumers

Secondary Data Sources

  • Annual Reports/SEC Filings/ Investor Presentations/ Press Releases
  • Government/Associations Publications
  • Case Studies
  • Reference Customers

 

Market Modeling and Forecasting

We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.

  • Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
  • Number of patients for particular device or medical procedure and
  • Repeated use of particular device depending on health and condition of patient
  • Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.

We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.

Data Validation

We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.

Data Triangulation

data triangulation

Industry Analysis

Qualitative Data

Quantitative Data (2017-2025)

  • Market Dynamics (Drivers, Restraints, and Challenges)
  • Industry Trend Analysis
  • Market Opportunities
  • Government Policies and Regulations, Patent Analysis, and Reimbursement Policies
  • Porter’s Five Forces and PESTLE Analysis
  • Key Developments and Competitive Landscape
  • Market Assessment and Forecast
  • Market Assessment and Forecast, By Product
  • Market Assessment and Forecast, By Technology
  • Market Assessment and Forecast, By Application
  • Market Assessment and Forecast, By End User
  • Market Assessment and Forecast, By Region/Country

License Type

For Any Assistance

*
*
*
*
*